TN2010000621A1 - Human cytomegalovirus neutralizing antibodies and use thereof - Google Patents

Human cytomegalovirus neutralizing antibodies and use thereof

Info

Publication number: TN2010000621A1
Authority: TN; Tunisia
Prior art keywords: antibodies; antibody fragments; neutralizing antibodies; human cytomegalovirus; relates
Prior art date: 2009-07-15

Application number

TNP2010000621A

Other languages

English (en)

Inventor

Antonio Lanzavecchia

Annalisa Macagno

Original Assignee

Inst Research In Biomedicine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-07-15

Filing date

2010-12-29

Publication date

2012-05-24

2009-07-15 Priority claimed from PCT/IB2009/006641 external-priority patent/WO2010007533A2/fr

2010-12-29 Application filed by Inst Research In Biomedicine filed Critical Inst Research In Biomedicine

2012-05-24 Publication of TN2010000621A1 publication Critical patent/TN2010000621A1/fr

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

TNP2010000621A 2009-07-15 2010-12-29 Human cytomegalovirus neutralizing antibodies and use thereof TN2010000621A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IB2009/006641 WO2010007533A2 (fr)	2008-07-16	2009-07-15	Anticorps neutralisant le cytomégalovirus humain et utilisation de ceux-ci

Publications (1)

Publication Number	Publication Date
TN2010000621A1 true TN2010000621A1 (en)	2012-05-24

Family

ID=55024691

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2010000621A TN2010000621A1 (en)	2009-07-15	2010-12-29	Human cytomegalovirus neutralizing antibodies and use thereof

Country Status (1)

Country	Link
TN (1)	TN2010000621A1 (fr)

2010
- 2010-12-29 TN TNP2010000621A patent/TN2010000621A1/fr unknown

Similar Documents

Publication	Publication Date	Title
PH12015500782A1 (en)	2015-12-14	Human cytomegalovirus neutralizing antibodies and use thereof
MY161200A (en)	2017-04-14	Human cytomegalovirus neutralising antibodies and use thereof
IN2014KN02933A (fr)	2015-05-08
WO2010017103A3 (fr)	2010-04-01	Anticorps monoclonaux anti-nkg2d humain entièrement humains
WO2011092593A3 (fr)	2011-10-27	Anticorps neutralisant le vih-1 et leurs utilisations
MX350200B (es)	2017-08-30	Anticuerpos humanos y conjugados de anticuerpo-farmaco contra cd74.
PH12012501549A1 (en)	2016-09-09	Cd127 binding proteins
SG184310A1 (en)	2012-10-30	Antibodies that bind human cd27 and uses thereof
PH12013500333A1 (en)	2013-04-22	Antibodies for epidermal growth factor receptor 3 (her3)
NZ592054A (en)	2013-06-28	Dengue virus neutralizing antibodies and uses thereof
MX2011012039A (es)	2011-12-14	Anticuerpos bloqueadores anti-dkk-1 y sus usos.
EP2566890A4 (fr)	2013-11-20	Anticorps anti-pai-1 et leurs procédés d'utilisation
PH12013500933A1 (en)	2017-08-23	Methods and compositions for neural disease immunotherapy
MX2012002458A (es)	2012-03-14	Anticuerpos anti-cdcp1 humanizados.
MX2015008534A (es)	2017-07-04	COMPOSICIONES DE ANTICUERPO ANTI-INTEGRINA ß1 Y METODOS DE USO DE LAS MISMAS.
HK1207970A1 (en)	2016-02-19	Agents for influenza neutralization
PH12013500432A1 (en)	2017-08-23	Anti-vegfr-3 antibody compositions
WO2012031260A3 (fr)	2012-07-19	Anticorps polyclonaux humains recombinés spécifiques du staphylocoque doré et utilisations de ceux-ci
WO2012022734A3 (fr)	2012-05-03	Anticorps anti-icam-1 et procédés d'utilisation
TN2010000621A1 (en)	2012-05-24	Human cytomegalovirus neutralizing antibodies and use thereof
HK1156052A (en)	2012-06-01	Human cytomegalovirus neutralising antibodies and use thereof
TN2011000028A1 (en)	2012-09-05	Neutralizing anti-influenza a virus antibodies and uses therof
TN2013000040A1 (en)	2014-06-25	Antibodies for epidermal growth factor receptor 3 (her3)
TN2013000068A1 (en)	2014-06-25	Anti-vegfr-3 antibody compositions